Delivery Order SPE2DE24D0013-SPE2D625F2SCC
- Not listed
- Cepheid, a Sunnyvale, California-based molecular diagnostics manufacturer, was awarded a delivery order valued at $13,096.80 on September 18, 2025, by the Defense Logistics Agency's Medical Supply Chain division. The delivery order, designated XPCOV2/FLU/RSV-10, is structured as a firm fixed-price contract with no set-aside designation and is scheduled for completion by October 2, 2025. Based on the contract designation and Cepheid's core product offerings, this delivery order appears to procure...
- Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 by the Defense Logistics Agency's Medical Supply Chain division on August 22, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by August 29, 2025, and covers molecular diagnostic testing solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $3,400 by the Defense Logistics Agency (a component of the Department of Defense) on August 4, 2025, with a completion date of August 11, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves firm fixed-price procurement of diagnostic testing solutions, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection capabilities. This...
- Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 on September 10, 2025, by the Medical Supply Chain, a defense-focused federal agency. This delivery order, designated XPCOV2/FLU/RSV-10 with an ultimate completion date of September 17, 2025, is associated with Cepheid's larger Indefinite Delivery Vehicle (IDV) contract with the Veterans Affairs Veterans Integrated Service Network 21, valued at $2.5...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $13,179.30 firm fixed-price delivery order by the Medical Supply Chain (a Defense agency) on May 2, 2025, with completion scheduled for May 9, 2025. The delivery order, designated 4568136320 ! XPCOV2/FLU/RSV-10, is for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic testing solutions and carries no set-aside designation. The work will be performed in Sunnyvale,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $40,800 by the Defense Department's Medical Supply Chain on August 14, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for COVID-19, Influenza, and Respiratory Syncytial Virus (RSV) diagnostic testing solutions with an ultimate completion date of August 21, 2025. This award includes no set-aside designation and represents work to be...
- Cepheid Inc., a molecular diagnostics manufacturer headquartered in Sunnyvale, California, received a $7,480 firm fixed-price delivery order from the Medical Supply Chain (Defense) on September 9, 2025, with an ultimate completion date of September 23, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves the procurement of molecular diagnostic solutions, specifically test kits and related supplies for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award...
- Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, received a $4,198.65 firm fixed-price delivery order from the Medical Supply Chain, a defense-focused federal agency, on September 12, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, calls for the delivery of diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing, with an ultimate completion date of September 19, 2025. This contract award carries no set-aside...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $6,631.72 firm fixed-price delivery order by the Defense Department's Medical Supply Chain on September 5, 2025, with an ultimate completion date of September 12, 2025. The contract, designated XPCOV2/FLU/RSV-10, calls for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic products and services, with performance occurring at Cepheid's Sunnyvale facility. This award carries...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $4,080.00 by the Defense Department's Medical Supply Chain on August 12, 2025. This firm fixed-price contract, designated as 4569079038 for XPCOV2/FLU/RSV-10, is scheduled for ultimate completion by August 19, 2025, with performance taking place in Sunnyvale, California. The contract carries no set-aside designation and represents a delivery order likely drawn from...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F2SCCDelivery Order
Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $5,440 on September 5, 2025, by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The delivery order, identified as XPCOV2/FLU/RSV-10, is structured as a firm fixed-price contract with no set-aside designation and calls for completion by September 12, 2025. Based on the contract nomenclature and Cepheid's product portfolio, this delivery order pertains to molecular diagnostic testing solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV), likely involving reagents, test kits, or associated diagnostic equipment from the company's GeneXpert diagnostic systems platform. This award appears to be issued under one of Cepheid's existing Indefinite Delivery/Indefinite Quantity (IDIQ) contracts with the Veterans Administration or Defense Health Agency, which serve as the primary vehicles for the company's provision of molecular diagnostic services across federal healthcare systems. Cepheid maintains substantial IDIQ authority through multiple VA agreements, including a single-award IDV with VA's Veterans Integrated Service Network 6 valued at approximately $32.8 million through 2030, which enables the company to fulfill episodic delivery orders like this one for infectious disease diagnostic testing across the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 9/5/25 |